After receiving approval from DGCI for restricted emergency use of Covid-19 vaccine Sputnik V, Dr Reddy’s Laboratories on Tuesday said it expects a lot of stock from Russian Direct Investment Fund by May end.
In September 2020, Dr Reddy’s and RDIF entered into a partnership to conduct clinical trials of Sputnik V, developed by the Gamaleya National Research Institute of Epidemiology and Microbiology and the rights for distribution of the first 100 million doses in India.
